News & Videos - DIPLOMAT PHARMACY INC. - Page 4

Diplomat to Release Q1 2018 Operating Results, Host Conference Call on May 7 PR Newswire FLINT, Mich., April 23, 2018 FLINT, Mich. , April 23, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), will release its first-quarter 2018 operating results after market close Monday, May 7 , with a conference call to follow at 5 p.m. ET . Shareholders and interested participants can listen to a live broadcast by calling 833.286.5805 (647.689.4450 for international callers) and entering participant...

Diplomat to Present at 2018 Needham & Company Healthcare Conference PR Newswire FLINT, Mich., March 19, 2018 FLINT, Mich. , March 19, 2018 /PRNewswire/ -- Diplomat Pharmacy Inc. (NYSE: DPLO) will participate in Needham & Company's 17th annual healthcare conference in New York City . Interim CEO Jeff Park and Chief Financial Officer Atul Kavthekar are scheduled to present at 11:30 a.m. ET Wednesday , March 28. Live audio-only webcasts of the presentation and related materials will be available on...

Diplomat to Present at 2018 Barclays Global Healthcare Conference PR Newswire FLINT, Mich., March 13, 2018 FLINT, Mich. , March 13, 2018 /PRNewswire/ -- Diplomat Pharmacy Inc. (NYSE: DPLO) will send executives to the 2018 Barclays Global Healthcare Conference in Miami, Florida . ­Interim CEO Jeff Park , President Joel Saban , and Chief Financial Officer Atul Kavthekar are scheduled to present at 2:35 p.m. ET Wednesday , March 14. To learn more about Diplomat, visit diplomat.is . About Diplomat...

Diplomat Announces 4th Quarter and 2017 Year End Financial Results; Provides 2018 Guidance 4th Quarter Revenue of $1,155 Million, Net Income Attributable to Diplomat of $6.5 Million, Adjusted EBITDA of $26.6 Million Full Year Revenue of $4,485 Million, Net Income Attributable to Diplomat of $15.5 Million, Adjusted EBITDA of $101.8 Million PR Newswire FLINT, Mich., Feb. 26, 2018 FLINT, Mich. , Feb. 26, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent...

NEW YORK, NY / ACCESSWIRE / February 26, 2018 / Diplomat Pharmacy, Inc. (NYSE: DPLO ) will be discussing their earnings results in their Q4 Earnings Call to be held on February 26, 2018 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/3253 To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network...

Diplomat Managing Rising Drug Costs to Support Patients The nation's largest independent provider of specialty pharmacy services outlines initiatives to control rising drug costs. PR Newswire FLINT, Mich., Feb. 21, 2018 FLINT, Mich. , Feb. 21, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) plans to combat rising healthcare costs throughout 2018 by advancing generic drugs, biosimilars, and affordable brand medications. Joel Saban , president of Diplomat, said the growing market for...

Diplomat to Release Fourth Quarter and 2017 Year End Financial Results, Provide 2018 Guidance and Host Conference Call On Monday, February 26, 2018 PR Newswire FLINT, Mich., Feb. 20, 2018 FLINT, Mich. , Feb. 20, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it will release its fourth quarter and 2017 year end financial results and provide 2018 guidance on Monday, February 26, 2018 after market close, with a conference call to follow at 5:00 p.m. ET . Shareholders...

Diplomat Dispensing Advanced Kidney Treatment, CABOMETYX® The nation's largest independent specialty pharmacy is dispensing CABOMETYX® (cabozantinib) tablets, now with an expanded indication to include first-line therapy for patients with advanced renal cell carcinoma PR Newswire FLINT, Mich., Jan. 15, 2018 FLINT, Mich. , Jan. 15, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) is dispensing Exelixis' limited-distribution treatment CABOMETYX ® (cabozantinib), now with an expanded...

Diplomat Initiates CEO Transition; Reaffirms 2017 Guidance and Provides Preliminary 2018 Outlook Appoints Jeff Park as Interim Chief Executive Officer Following Retirement of Phil Hagerman Mr. Hagerman to Continue Service on Board and Become Chairman Emeritus; Ben Wolin, Lead Director, Appointed Chairman PR Newswire FLINT, Mich., Jan. 5, 2018 FLINT, Mich. , Jan. 5, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) ("Diplomat" or the "Company") today announced that Jeff Park , a member of...

Diplomat Reaffirms 2017 Guidance, Provides Preliminary 2018 Outlook The nation's largest independent provider of specialty pharmacy services announces reaffirmed guidance for 2017 and preliminary 2018 projections. PR Newswire FLINT, Mich., Jan. 5, 2018 FLINT, Mich. , Jan. 5, 2018 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) has reaffirmed guidance for the full-year 2017 and provided a preliminary 2018 outlook. Diplomat preliminarily expects 2017 revenue to be near the middle of the...

Diplomat Completes Acquisition of LDI Integrated Pharmacy Services, Secures New Credit Facilities The nation's largest independent provider of specialty pharmacy services closes deal to acquire pharmacy benefit manager and announces new $800 million senior secured credit facilities. PR Newswire FLINT, Mich., Dec. 20, 2017 FLINT, Mich. , Dec. 20, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has completed its acquisition of Leehar Distributors, LLC, doing business as LDI Integrated...

Diplomat to Participate in 36th Annual J.P. Morgan Healthcare Conference PR Newswire FLINT, Mich., Dec. 20, 2017 FLINT, Mich. , Dec. 20, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has announced that Phil Hagerman , CEO and chairman, and Atul Kavthekar , CFO, will present at the upcoming 36 th Annual J.P. Morgan Healthcare Conference in San Francisco, CA. Mr. Hagerman and Mr. Kavthekar are scheduled to present at the conference on Wednesday, Jan. 10, 2018 , at 1:30 p.m. PT . A...

Diplomat Adds Chris Luthin as Executive Vice President Executive with experience in pharmacy benefit manager integration joins the nation's largest independent provider of specialty pharmacy services PR Newswire FLINT, Mich., Dec. 11, 2017 FLINT, Mich. , Dec. 11, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has hired Chris Luthin to serve its pharmacy benefit manager (PBM) arm as executive vice president of finance, pharmacy benefit management, and integration. The company...

Diplomat to Acquire LDI Integrated Pharmacy Services The nation's largest independent provider of specialty pharmacy services will add a pharmacy benefit manager, accelerating its evolution to a broader health care company. PR Newswire FLINT, Mich., Nov. 15, 2017 FLINT, Mich. , Nov. 15, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has entered into a definitive agreement to acquire Leehar Distributors, LLC, doing business as LDI Integrated Pharmacy Services (LDI), from investment...

Diplomat Announces 3rd Quarter Financial Results 3rd Quarter Revenue of $1,125 Million, Net Income Attributable to Diplomat of $1.0 Million, Adjusted EBITDA of $23.2 Million PR Newswire FLINT, Mich., Nov. 6, 2017 FLINT, Mich. , Nov. 6, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), the nation's largest independent provider of specialty pharmacy services, announced financial results for the quarter ended September 30 , 2017. All comparisons, unless otherwise noted, are to the quarter...

Diplomat to Acquire National Pharmaceutical Services The nation's largest independent provider of specialty pharmacy services adds a pharmacy benefit manager to bolster clinical and technology offerings. PR Newswire FLINT, Mich., Nov. 6, 2017 FLINT, Mich. , Nov. 6, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO), has entered into a definitive agreement to acquire Pharmaceutical Technologies, Inc., doing business as National Pharmaceutical Services . The transaction is expected to close...

NEW YORK, NY / ACCESSWIRE / November 6, 2017 / Diplomat Pharmacy, Inc. (NYSE: DPLO ) will be discussing their earnings results in their Q3 Earnings Call to be held on November 6, 2017 at 5:00 PM Eastern Time. To listen to the event live or access a replay of the call - visit https://www.investornetwork.com/company/3253 . To receive updates for this company you can register by emailing [email protected] or by clicking get investment info from the company's profile. About Investor Network...

Diplomat Selected to Dispense CALQUENCE® for Previously-Treated Mantle Cell Lymphoma The nation's largest independent provider of specialty pharmacy services has been selected as a limited distributor for CALQUENCE® (acalabrutinib) PR Newswire FLINT, Mich., Nov. 1, 2017 FLINT, Mich. , Nov. 1, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) has been named to the limited pharmacy panel to dispense CALQUENCE ® (acalabrutinib). CALQUENCE, recently granted accelerated approval by the...

Diplomat Names Executive Vice President of Sales, Payor Strategies The nation's largest independent provider of specialty pharmacy services has named Robyn Peters executive vice president of sales and payor strategies PR Newswire FLINT, Mich., Oct. 30, 2017 FLINT, Mich. , Oct. 30, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) has hired Robyn Peters as executive vice president of sales and payor strategies. As a member of Diplomat's executive leadership team, Peters will oversee payor...

Diplomat to Release Third Quarter 2017 Operating Results and Host Conference Call on Monday, November 6, 2017 PR Newswire FLINT, Mich., Oct. 16, 2017 FLINT, Mich. , Oct. 16, 2017 /PRNewswire/ -- Diplomat Pharmacy, Inc. (NYSE: DPLO) announced today that it will release its third quarter 2017 operating results on Monday, November 6, 2017 after market close, with a conference call to follow at 5:00 p.m. ET . Shareholders and interested participants may listen to a live broadcast of the conference...